Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
3.970
+0.040 (1.01%)
Mar 31, 2025, 2:31 PM EDT - Market open
Genenta Science Market Cap
Genenta Science has a market cap or net worth of $72.61 million as of March 31, 2025. Its market cap has decreased by -0.35% in one year.
Market Cap
72.61M
Enterprise Value
60.05M
1-Year Change
-0.35%
Ranking
Category
Stock Price
$3.97
Market Cap Chart
Since the IPO on December 15, 2021, Genenta Science's market cap has decreased from $208.76M to $72.61M, a decrease of -65.22%. That is a compound annual growth rate of -27.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 72.61M | -8.74% |
| Dec 31, 2024 | 79.56M | -11.77% |
| Dec 29, 2023 | 90.17M | -10.00% |
| Dec 30, 2022 | 100.19M | -49.56% |
| Dec 31, 2021 | 198.63M | -4.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |